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Abstract
The protective mechanisms of microglia cells help to maintain central nervous system (CNS) homeostasis
and function.1 Microglia are innate immune cells that constantly survey their surrounding CNS
microenvironment for pathogens, damaged cells, and inflammatory molecules. Sugars from our diet, including
glucose and fructose, combine with endogenous proteins non-enzymatically and form advanced glycation-
end products (AGEs).2 AGEs are shown to produce reactive oxygen species, leading to inflammation and
cellular damage that may be mediated by microglia.3 Fructose consumption has become increasingly
prevalent within the American diet, as it is a lower cost sweetener.4 Microglia become activated and
phagocytic in the presence of high levels of glucose, but the effects of fructose are not yet fully understood.3
The reactivity of fructose within the body and it’s long-term health implications remain unclear.
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Introduction 
The protective mechanisms of microglia cells help to maintain 
central nervous system (CNS) homeostasis and function.1 
Microglia are innate immune cells that constantly survey their 
surrounding CNS microenvironment for pathogens, damaged 
cells, and inflammatory molecules. Sugars from our diet, 
including glucose and fructose, combine with endogenous 
proteins non-enzymatically and form advanced glycation-end 
products (AGEs).2 AGEs are shown to produce reactive oxygen 
species, leading to inflammation and cellular damage that may 
be mediated by microglia.3 Fructose consumption has become 
increasingly prevalent within the American diet, as it is a lower 
cost sweetener.4 Microglia become activated and phagocytic in 
the presence of high levels of glucose, but the effects of fructose 
are not yet fully understood.3 The reactivity of fructose within the 
body and it’s long-term health implications remain unclear.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Objective 
Fructose has been shown to produce a faster rate of glycation, or 
AGE formation, compared to glucose.2 The accumulation of 
AGEs in the body causes damage and negatively impacts health. 
AGE formation occurs as part of the natural aging process, but is 
also associated with diabetes and neurodegenerative diseases, 
such as Alzheimer’s and multiple sclerosis.3 The goal of this 
research was to compare the reactivity of fructose and glucose 
as well as the viability of microglia treated with each sugar.  
 Methods 
To measure AGE production in a non-cellular environment, 1M 
glucose or fructose was incubated at 37˚C with 1mM bovine 
serum albumin for eight weeks. Weekly fluorescence readings of 
each sample were made to measure the amount of glucose-AGE 
(Glu-AGE) and fructose-AGE (Fru-AGE) production. In vitro 
effects of glucose and fructose were observed by measuring 
microglia viability and AGE production after treatment with 
glucose or fructose.  An immortalized microglial cell line (HAPI) 
was treated with control media and fructose 100, 50, 25 and 
10mM or the equivalent concentrations of glucose. Cell survival 
was measured following a 24 hour incubation using an MTT 
assay. In vitro AGE production was measured using an anti-AGE 
antibody via Western Blot.  AGE production was quantified after 
a 24 hour incubation, in the presence of fructose 100, 50, 25 and 
10mM, glucose 50mM, or control. Statistical analysis included a 
one-way ANOVA with a Tukey post-hoc test; p-values less than 
0.05 were considered significant. non-cellular environment, 1M glucose or 
Conclusions 
• Both fructose and glucose are shown to be reactive and 
detrimental to cells in cellular and non-cellular environments.  
 
• At higher concentrations, both sugars resulted in AGE 
formation and cellular death.  
 
• Fructose glycation occurs at a higher rate than glucose 
glycation in a non-cellular environment (Figures 1 and 2). 
 
• The highest sugar concentrations tested, glucose 100mM and 
fructose 100mM, both significantly decreased microglia cell 
survival.  Fructose 50mM also significantly reduce cell survival 
(Figures 3 and 4).  
 
• Cell viability is reduced at a higher level in fructose-treated 
cells compared to treatment with equivalent concentrations of 
glucose (Figures 3 and 4).   
 
• A higher rate and amount of Fru-AGE production was seen in 
cells treated with 100mM and 50mM fructose eluding that 
fructose may have more potent deleterious effects than 
glucose (Figure 5).  
 
• Our data suggests that fructose may be more reactive and 
produce more deleterious effects than glucose, but more data 
are needed to determine if higher Fru-AGE production causes 
greater cellular damage and inflammation in vitro and in vivo.  
References 
1. Sierra A, Becarri S, Diaz-Aparicio I, et al. Surveillance, Phagocytosis, 
        and Inflammation: How Never-Resting Microglia Influence Adult 
        Hippocampal Neurogenesis. Neur Plast. 2014;1-15. 
2.     Suarez G, Rajaram R, Oronsky AL, et al. Nonenzymatic Glycation of 
        Bovine Serum Albumin by Fructose (Fructation): Comparison with the 
        maillard reaction initiated by glucose. J Biol Chem. 1989;264:3674-9. 
3.  Lull ME, Block ML. Microglial activation and chronic 
        neurodegeneration. Neurotherapeutics; 2010;7(4):354-65. 
4.  Feinman RD, Fine EJ. Fructose in perspective. Nutr Metab (Lond). 
        2013;10(1):45. 
 
Disclosures 
Authors of this presentation have personal or financial interest in the subject matter of this 
presentation. 
 
Regina Blackley: Nothing to disclose 
Matthew Stryker: Nothing to disclose 
Susan DeNapoli: Nothing to disclose 
Melinda E. Lull: Nothing to disclose 
0
20
40
60
80
100
120
140
160
180
Fl
uo
re
sc
en
ce
 
Time (weeks) 
Fluorescence Weeks 1 through 4 
Glu-AGE Fru-AGE
0
20
40
60
80
100
120
Control Glu100mM Glu75mM Glu50mM Glu25mM Glu10mM
Av
er
ag
e 
%
 o
f C
on
tro
l * 
** 
0
20
40
60
80
100
120
140
Control Fru100mM Fru50mM Fru25mM Fru10mM
A
ve
ra
ge
 %
 o
f C
on
tro
l 
Figure 1. Glu-AGE and Fru-AGE production. Left: Change in Glu-AGE 
production from week 1 to week 4. Right: Change in Fru-AGE production 
from week 1 to week 4. Change in color signifies AGE production. 
Control        Glu 50mM    Fru 10mM   Fru 25mM    Fru 50mM    Fru 100mM
  
Figure 5. AGE-protein production in HAPI cells. An anti-AGE antibody 
was used to quantify the amount of AGEs produced in HAPI cells when 
treated with glucose or fructose.  AGE protein production increased as 
fructose concentration increased, with the exception of Fructose 100mM.  
The quantity of Fructose 50mM was greater than twice that of Glucose 
50mM. (5A)  A representative western blot image is shown in 5B. 
Figure 3. Effect of glucose on microglia survival. Glucose 100mM was the 
only treatment to significantly decrease cell survival compared to control. Cell 
survival increased proportionately as glucose concentration decreased. *p<0.05 
Quantification of Glu-AGE vs Fru-AGE 
Production 
Figure 2. Weekly fluorescence readings of Glu- and Fru-AGEs. Increases 
in fluorescence each week indicates the reaction between sugars and bovine 
serum albumin (BSA). Fructose has a faster rate of glycation than glucose.  
Figure 4. Effect of fructose on microglia survival. Fructose 100 and 50mM 
significantly decreased cell survival compared to control. Cell survival increased 
proportionately as concentrations decreased. **p<0.001, *p<0.05 
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